Gudang Garam Stock Continues to Decline in Indonesia's Anti-Smoking Campaign

Dec.08.2022
Gudang Garam Stock Continues to Decline in Indonesia's Anti-Smoking Campaign
Susilo Wonowidjojo's wealth declined due to falling stocks of his family's cigarette company, Gudang Garam, amid anti-smoking campaigns.

Susilo Wonowidjojo's wealth has further declined this year as the stock of his family's cigarette manufacturer Gudang Garam continues its three-year slump amid the Indonesian government's anti-smoking campaign. His net worth dropped by 27% to $3.5 billion, placing him at 14th on Indonesia's richest 50 list, down seven spots from last year.


Despite a slight improvement in sales during the first nine months of 2022, net profit has decreased by 64% year-on-year to 15 trillion Indonesian rupiahs (96 million US dollars), primarily due to the government's increase in tobacco consumption tax in January (following a 27% drop in revenue in 2021). Taxes make up over 85% of the company's total sales costs, resulting in a profit margin of 1.6%, down from 4.4% last year. Additionally, in November, Finance Minister Sri Mulyani Indrawati announced additional tax increases in 2023 and 2024. The company has stated its plans to raise prices.


In recent years, Indonesia has strengthened its measures to combat smoking, especially among young people. Approximately one quarter of the country's 276 million population smoke cigarettes. Overseas sales for Gudang Garam have also declined, dropping nearly 15% year-on-year in 2021 to 1.8 billion cigarettes. The company diversified its operations in 2019 with the construction of toll roads and is currently building the Dhoho airport in Kediri, East Java at a cost of 600 million dollars, which is expected to open in October of next year.


Gudang Garam was founded in 1958 by Susilo's father, Surya Wonowidjojo. Since 2009, Susilo has served as the CEO of the Kediri-based company, with his sister Juni Setiawati serving as the executive commissioner. In June, Susilo's son Indra was appointed as the Vice President Director.


2FIRSTS will continue to report on this issue, with further updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
Philip Morris Japan (PMJ) announced that it will launch “SENTIA Purple Capsule,” the first capsule-equipped product in its SENTIA lineup dedicated to the heated tobacco “IQOS ILUMA” series, as an early release in Japan. The product will roll out nationwide starting from IQOS Stores, and will enter tobacco retail channels nationwide from April 6.
Mar.03 by 2FIRSTS.ai
South Korea’s finance ministry to directly crack down on illegal high-nicotine vape liquids
South Korea’s finance ministry to directly crack down on illegal high-nicotine vape liquids
The report says South Korea’s Ministry of Economy and Finance (referred to as the finance ministry) will directly lead crackdowns on illegal distribution and “upward manipulation” of nicotine concentrations in liquid e-cigarettes, after cases of extremely high-strength nicotine liquids circulating at retail shops were highlighted.
Feb.28 by 2FIRSTS.ai
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea’s Health Ministry says amendments to the Tobacco Business Act will take effect on April 24, bringing synthetic-nicotine e-liquid vapes under the legal definition of tobacco. The shift extends cigarette-style rules to these products, including mandatory graphic warnings, sharply limited advertising channels, stricter vending-machine placement requirements, and a ban on use in smoke-free areas, with enforcement checks slated from late April.
Feb.03 by 2FIRSTS.ai
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco (JT) said it has applied to raise retail prices for its heated tobacco-related products from April 1, 2026, covering 37 variants of Ploom tobacco sticks and with capsules, with most increases at 20–30 yen per pack (about $0.13–$0.19).
Jan.28 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai